Vaccine Maker Beats Investor Suit Over Private Investment
Chinese vaccine maker Sinovac Biotech Ltd. no longer faces an investor's proposed class action alleging the company diluted public shareholders' equity with a private investment in public equity transaction after a...To view the full article, register now.
Already a subscriber? Click here to view full article